The global Proton Pump Inhibitors Market has been experiencing significant growth, primarily driven by the increasing prevalence of gastroesophageal reflux disease (GERD) worldwide. GERD is a chronic condition characterized by the backflow of stomach acid into the esophagus, leading to discomfort and potential complications. Factors such as changing dietary patterns, sedentary lifestyles, and obesity have contributed to the rising cases of GERD. As a result, there has been a growing demand ... Read more
The global Proton Pump Inhibitors Market is estimated to be valued at US$ 2.9 billion in 2020 and is expected to exhibit a CAGR of 4.30% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
Proton pump inhibitors (PPIs) are a class of drugs used to reduce the production of stomach acid. They are primarily prescribed for the treatment of gastroesophageal reflux disease (GERD), peptic ... Read more
The Proton Pump Inhibitors (PPIs) market is estimated to be valued at US$ 2.9 billion in 2023 and is expected to exhibit a CAGR of 4.30% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Proton pump inhibitors are a class of drugs that reduce the production of stomach acid. These drugs are primarily used for the treatment of ... Read more
Proton Pump Inhibitors are a type of medications that work by reducing the amount of acid produced in the stomach. They are commonly used for treating gastric and duodenal ulcers, gastroesophageal reflux disease and other conditions caused by excessive stomach acid. These medications provide effective relief from symptoms such as heartburn and acid regurgitation. With rising geriatric population worldwide, the incidence of acid-related disorders has increased at an alarming rate. According ... Read more
